Evaluation of lymph node surgery in patients with upper urinary tract carcinoma

Not Applicable

• Conditions: rothelial carcinoma of the upper urinary tract; Cancer; Urothelial carcinoma of the upper urinary tract

• Registration Number: ISRCTN83155790
• Lead Sponsor: und University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2015-10-07
• Last Update Posted: 22 January 2024
• Study Completion: 2028-01-01

Recruitment & Eligibility

• Status: Ongoing
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

1. Aged 18 years or over
2. Locally advanced high grade urothelial carcinoma in the renal pelvis or upper 2/3 of the ureter (Clinical stage > T1)

Exclusion Criteria

Clinical suspicion of non-muscle invasive UUTUC

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
ocation of lymph node metastasis measured at retroperitoneal lymphadenectomy during follow up if the patients suffer from lymph node recurrence, within a two year period.

Secondary Outcome Measures

Name	Time	Method
Post surgical complications are monitored throughout 90 days after surgery, by examining patient charts. After 90 days, a Clavien score between 0 and 5 is determined.